Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6300+0.2000 (+5.83%)
At close: 04:00PM EDT
3.5500 -0.08 (-2.20%)
After hours: 06:58PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
140,702
144,927
33,215
34,505
28,267
Operating Expense
225,620
209,420
121,345
104,889
128,551
Operating Income
-84,918
-64,493
-88,130
-70,384
-100,284
Net Non Operating Interest Income Expense
-838
-40
-1,978
531
1,172
Other Income Expense
-981
-1,045
981
-426
170
Pretax Income
-86,737
-65,578
-89,127
-70,279
-98,942
Net Income Common Stockholders
-86,737
-65,578
-89,127
-70,279
-98,942
Diluted NI Available to Com Stockholders
-86,737
-65,578
-89,127
-70,279
-98,942
Basic EPS
-
-0.72
-1.12
-1.24
-2.43
Diluted EPS
-
-0.72
-1.12
-1.24
-2.43
Basic Average Shares
-
91,703
79,789
56,649
40,743
Diluted Average Shares
-
91,703
79,789
56,649
40,743
Total Operating Income as Reported
-84,918
-64,493
-88,130
-71,876
-100,284
Total Expenses
225,620
209,420
121,345
104,889
128,551
Net Income from Continuing & Discontinued Operation
-86,737
-65,578
-89,127
-70,279
-98,942
Normalized Income
-86,737
-65,578
-89,127
-68,787
-98,942
Interest Income
2,288
2,870
946
1,033
-
Interest Expense
3,126
2,910
2,924
502
-
Net Interest Income
-838
-40
-1,978
531
1,172
EBIT
-83,611
-62,668
-86,203
-69,777
-100,284
EBITDA
-77,570
-
-
-
-
Reconciled Depreciation
6,041
5,947
6,578
7,603
7,862
Net Income from Continuing Operation Net Minority Interest
-86,737
-65,578
-89,127
-70,279
-98,942
Total Unusual Items Excluding Goodwill
0
0
0
-1,492
-
Total Unusual Items
0
0
0
-1,492
-
Normalized EBITDA
-77,570
-56,721
-79,625
-60,682
-92,422
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement